glutamic acid has been researched along with cholestane-3,5,6-triol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, W; Hu, H; Huang, Y; Leng, T; Liu, A; Qiu, P; Sang, H; Tang, L; Wang, L; Wang, Y; Yan, G; Yin, W; You, X; Zhang, J; Zhou, Y | 1 |
Chen, XY; Huang, YJ; Leng, TD; Liu, AL; Ou, YQ; Qiu, PX; Su, XW; Tang, LP; Yan, GM; Yan, M; Yin, W; Zhang, JX; Zhou, SJ | 1 |
2 other study(ies) available for glutamic acid and cholestane-3,5,6-triol
Article | Year |
---|---|
The major cholesterol metabolite cholestane-3β,5α,6β-triol functions as an endogenous neuroprotectant.
Topics: Adult; Animals; Brain Injuries; Cells, Cultured; Central Nervous System; Cholestanols; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Spinal Cord Ischemia; Time Factors; Tissue Distribution; Young Adult | 2014 |
Characterization of a Synthetic Steroid 24-keto-cholest-5-en-3β, 19-diol as a Neuroprotectant.
Topics: Animals; Animals, Newborn; Calcium; Cell Hypoxia; Cells, Cultured; Cerebellum; Cholestanols; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley | 2015 |